Incheon, South Korea

Jun Seok Oh

This inventor holds 6 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Celltrion Inc.. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jun Seok Oh. Retrieved from https://idiyas.com/inventor/jun-seok-oh-572yuz7o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 7.8

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Jun Seok Oh: A Pioneer in Pharmaceutical Formulations

Introduction

Jun Seok Oh is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stable liquid preparations for antibodies. With a total of six patents to his name, his work is crucial in advancing medical treatments.

Latest Patents

Among his latest patents, Jun Seok Oh has developed a stable liquid pharmaceutical formulation of an anti-influenza virus antibody. This formulation includes an anti-influenza virus antibody or a mixture of different types of antibodies, a surfactant, a sugar or sugar derivative, and an amino acid. The preparation boasts excellent storage stability at various temperatures, including low (5° C.), room (25° C.), and high (40° C.) temperatures. It also demonstrates long-term storage stability for up to 12 months and can be administered through various methods such as intravenously, intramuscularly, and topically.

Another significant patent involves a stable liquid formula comprising an anti-TNFa antibody, an acetate buffer, glycine, and a surfactant. This formulation is unique as it does not include sugar, sugar alcohol, or metal salts, yet remains stable even with high antibody content. It is superior in osmolality and viscosity, allowing for subcutaneous administration.

Career Highlights

Jun Seok Oh

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…